Rating date
Jul 20, 2026
21 days ago
Eli Lilly and Company Stock Analysis
OWLLY Equity Research — OVERWEIGHT — July 2026
Desk view
OW
5D move
—
Awaiting market data
Peer rank
19p
Research history
2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 moreInvestment card · LLY
Now I have all the data needed. Here is the full analysis.
Desk rating
OW
Tactical OW · 12M OW
Horizon
Long-term
Confidence
Medium
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Bias
OVERWEIGHT
Catalysts
- Long-term trend remains bullish. Price is well above both the 50-day and 200-day SMAs, and the moving averages are positively stacked. No trend reversal signal exists at the structural level.
- Short-term momentum has clearly stalled. The RSI dropping below 50 and MACD compressing sharply in July 2026 point to weakening buying conviction. This is the most notable technical change in recent weeks.
- The August 2025 crash zone (~$621) is far in the rearview mirror and appears to have been a buying opportunity in retrospect — though the cause warrants fundamental investigation.
Risks
- Event-driven repricing risk if expectations diverge from incoming evidence.
Market chart
Price context alongside the research narrative.
LLY Research Note
Full desk note for Jul 20, 2026. Use tabs for catalysts, valuation and risks, or open the full note.
WebserviceX · Agentic Research Desk
LLY Equity Research Note
LLY Stock Rating Summary
LLY bias
OVERWEIGHT
Horizon
Long-term
LLY key risk
Event-driven repricing risk if expectations diverge from incoming evidence.
LLY catalyst watch
Long-term trend remains bullish. Price is well above both the 50-day and 200-day SMAs, and the moving averages are positively stacked. No trend reversal signal exists at the structural level.
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Confidence
Medium
How the call aged · 5D
—Awaiting market dataPeer 19pExpandCollapse
How the call aged · 5D
—Awaiting market dataPeer 19p
Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-21T15:52:28.125393+00:00.
5D move
—
2026-07-20 → awaiting
Outcome
Awaiting market data
5D trend
-2.96%
Vol (20D ann.)
+35.32%
vs SPY: -2.01%
Close 1146.9 → — (USD, vendor closes)
Publish QC
passedExpandCollapse
Publish QC
passed
Pipeline fingerprint 2f45a102687f75c0
Trace c291778d…
No QC issues recorded.